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doi:10.1016/j.ejvs.2010.08.013Abstract Objectives: To determine the incidence and risk factors for spinal cord ischaemia
(SCI) following thoracic and thoracoabdominal aortic intervention.
Methods: A prospective database of all thoracic and thoracoabdominal aortic interventions
between 2001 and 2009 was used to investigate the incidence of SCI. All elective and emer-
gency cases for all indications were included. Logistic regression was used to investigate which
factors were associated with SCI.
Results: 235 patients underwent thoracic aortic stent grafting; 111(47%) thoracic aortic stent-
grafts alone, with an additional 14(6%) branched or fenestrated thoracic grafts, 30(13%) arch
hybrid procedures and 80(34%) visceral hybrid surgical and endovascular procedures. The
global incidence of SCI for all procedures was 23/235 (9.8%) and this included emergency indi-
cations (ruptured TAAA and acute complex dissections) but the incidence varied considerably
between types of procedures. Of the 23 cases, death occurred in 4 patients but recovery of
function was seen in 6. Thus, permanent paraplegia occurred in 13/235 (5.5%) patients. Of
the nine pre-specified factors investigated for association with SCI, only percentage of aortic
coverage was significantly associated with the incidence of SCI; adjusted odds ratio per 10%
increase in aorta covered Z 1.78[95% CI 1.18e2.71], p Z 0.007. The procedures in patients
who developed SCI took longer (463.5 versus 307.2 minutes) and utilised more stents
(4 versus 2).
Conclusion: SCI following thoracic and thoracoabdominal aortic endovascular intervention is
associated with the proportion of aorta covered. The degree of risk varies between different78867918; fax: þ44 2078862216.
c.uk (R.G.J. Gibbs).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Surgical repair of the thoracic and thoracoabdominal aortic
segments for a range of pathologies broadly encompassed by
degenerative atherosclerotic aneurysmal disease, Type B
dissections and theacuteaortic syndromecarries a significant
risk of spinal cord ischaemia (SCI), ranging from 5 to 20%.1,2
The great hope was that the advent of endovascular inter-
vention, with concomitant avoidance of proximal aortic cross
clamp, thoracotomy or thoracolaparotomy, would lead to
a reduction in complications including paraplegia. After
a decadeof experience the reported SCI rate is between0 and
10% for thoracic aortic endovascular repair3e21 and 0e30% for
thoracoabdominal aortic endovascular repair (see Table 1).
The evolution of endovascular and hybrid endovascular
techniques for thoracic and particularly thoracoabdominal
aneurysms is ongoing, and the considerable variance in
reported paraplegia rates mandates continued effort to
determine the underlying causes of SCI and thosemost at risk.
Potential mechanisms of ischaemic damage to the cord
include coverage of critical extrinsic vertebral, intercostal,
lumbar and internal iliac supply to theanterior spinal artery,22
peri-operative hypotension and possibly embolisation during
device introduction and deployment. A number of risk factors
have been identified, including disease pathology, extent and
length of the aorta covered, hypotension and coverage of the
left subclavian artery without revascularisation.16 In this
study we conducted a retrospective review of patients
undergoing thoracic (TEVAR) and thoracoabdominal aortic
intervention in order to determine the incidence and identify
risk factors for this grave complication.
Methods
The patients
Details of all aortic stent graft procedures covering part or all
of the thoracic aorta performed at StMary’s Hospital Imperialy or SCI after endovascular inte
N
4 (TAA)
15 (Arch)
31 (16 Arch, 15 TAA)
13 (TAA)
29 (TAA)
9 (TAA)
73 (TAA)
6 (TAA)
22 (TAA)
352 (TA þ TAA)
18 (8 Arch, 11 TAA)
8 (TAA)
ach.College Healthcare NHS Trust, between 2001 and 2009 were
recorded in a prospectively collected database. During the
time period in question all thoracic pathologies were treated
with stent-grafts. All Crawford extent I, II and III and arch
TAAAs were treated by a hybrid endovascular approach or
a total endovascularapproach.Type IVTAAAsweretreatedby
open surgery and excluded. Juxtarenal and difficult necked
infrarenal aneurysms treated by fenestrated or branched
endovascular grafts were excluded. All cases of patients with
neurological complications were identified, and the case
notes examined to determine those who had evidence of
spinal cord ischaemia. This was distinguished from cerebro-
vascular accident by the clinical signs (bilateral lower limb
versus unilateralweakness) andconfirmation frombrainCTor
MRI scans and spinal MRI. Any patient with unilateral leg
weakness underwent aCTbrain scan to exclude stroke aswell
as a spinal MRI to confirm cord infarction. A Consultant
neurologist reviewed all patients suspected of SCI post-
operatively The spinal cord ischaemia was further cat-
egorised into whether this was transient with complete
recovery during the hospital admission, whether there was
apartial defect (paraparesis), orwhether therewascomplete
paraplegia. SCI was categorised into immediate (immediate
or upon wakening) or delayed (occurring after a period of
normal neurological function). For all cases, information
including patient demographics, Crawford classification,
type of procedure, indication for treatment, urgency of
procedure, use of a spinal drain, procedure duration, number
of stents deployed, and left subclavian artery (LSA) coverage
with or without revascularisation, were gathered from the
database and theatre records. The presenting pathology is
demonstrated in Table 2. The majority of cases were degen-
erative atherosclerotic aneurysms treated electively, but the
series included chronic Type B dissections complicated by
aneurysmal degeneration and acute aortic syndrome. The
last category included acute Type B dissections complicated
by expansion, rupture or visceral or limb malperfusion,
symptomatic penetrating atherosclerotic ulcers and pseu-
doaneurysms and aortic transections. These constituted thervention for thoracoabdominal aortic aneurysms.
Mortality (%) SCI (%)
25 0
0 0
3.2 0
23 30
13 0
0 22
5.5 2.7
0 0
9.1 4.5
5.7 4.3
6 0
0 12
Table 2 Presenting pathology.
Pathology Urgency Patients with SCI % with SCI
Aneurysmal disease Emergency 2/13 15.4
Urgent 1/15 6.7
Elective/NA 11/104 10.6
Chronic dissection Emergency 0/2 0
Urgent 0/7 0
Elective/NA 4/36 11.1
Acute Aortic Syndrome Emergency 4/22 18.2
Urgent 1/16 6.3
Risk of SCI in Thoracic Aortic Stenting 731highest risk group for development of SCI. Of the five patients
who developed SCI two had penetrating aortic ulcers with
rupture, one suffered a ruptured anastamotic aneurysm
following open TAAA repair 30 years previously, one had an
aortic transaction and one an acute dissection. All were
treated with thoracic endografts except the ruptured anas-
tamotic aneurysm who underwent an emergency visceral
hybrid repair. The post-operative CT scans were then
obtained, where available, and loaded onto a CTworkstation
(Philips). The length of aorta stented and the total aortic
length from the origin of the brachiocephalic artery to
the iliac bifurcationweremeasured, in order to calculate the
percentage of aorta covered (see Fig. 1). The aortic segments
weremeasuredusinga reformattedobliquecoronal view.The
image thickness was changed to 30 mm on the workstation to
account for tortuosity of the aorta. All measurements were
made along a central luminal line. The brachiocephalic origin
was used as the first point of measurement to ensure that all
segments of the aorta contributing arterial branches to theFigure 1 Image of aorta showing measurements taken of
length of aorta from brachiocephalic origin to iliac bifurcation
and stent length.spinal cord were included. Measurements were taken just
distal to the braciocephalic and the origin was not included.
We categorised procedure into four groups: TEVAR (stent
deployment in the thoracic aorta alone), arch hybrid
(stent deployment in the arch/thoracic aorta with coverage
of one or more arch branches necessitating revascularisa-
tion), visceral hybrid (stent deployment in the thoracic and
abdominal aorta necessitating visceral debranching and
revascularisation) and a wholly endovascular branch/fenes-
trated group. Latterly in the series we have adopted a total
endovascular approach to thoracoabdominal aneurysms
(TAAAs) in suitable cases utilising branch grafts or coeliac
fenestrations for thoracic aneurysms with a very short distal
landing zone. This group does not include branched or
fenestrated endografts for juxtarenal or infrarenal aneu-
rysms with a hostile neck.
Statistical Analysis
Statistical analysis was performed using Stata version 10
(Stata Corporation, Texas, USA). Logistic regression model-
ling was used to assess whether any of nine pre-specified
factors were associated with the incidence of spinal cord
ischaemia. Histograms and Normal plots were used to check
the distributions of continuous variables. Age and
percentage aortic coverage were approximately normally
distributed. Length of procedure was positively skewed but
log transformation improved the distribution markedly.
Therefore, median and interquartile ranges are used to
present the non-transformed length of procedure data but
log transformed values were included in the logistic regres-
sionmodel. Crude odds ratioswere calculated aswell as ones
adjusted for all other factors being assessed. This reduced
the size of the adjustedmodel to 17 SCI cases in 131 patients.
Imputation of missing data was considered but as the data
werenotmissing at randomandappeared tobe related to the
SCI outcome (post-operative CT scans missing from para-
plegic patients who died on ITU meant missing data con-
cerning accurate length of aorta stented), conventional
methods for inclusion of patients with missing data were not
undertaken. As 9 variables were being assessed on the same
sample, the p-value threshold for statistical significance was
reduced to 0.006 to account for multiple testing.
Results
A total of 235 patients were identified from the database.
23 patients developed spinal cord ischaemia, of whom
Figure 2 Box and whiskers plot to compare the percentage
of aorta stented in patients who developed spinal cord
ischaemia. The minimum percent aortic coverage that devel-
oped spinal cord ischaemia was 55%.
732 S.L. Drinkwater et al.four died within 30 days of the procedure. Two patients
suffered a temporary paralysis from which they made
a full recovery. Four patients experienced a partial
recovery, and thirteen patients suffered full and perma-
nent paraplegia, (see Table 3). One patient undergoing an
endovascular four vessel branch graft for a TAAA devel-
oped a delayed paraplegia on day 6 and subsequently died.
Unsurprisingly the rate of spinal cord ischaemia was very
low in patients with a stent graft confined to the thoracic
aorta, but was higher for those patients with arch hybrids
(involving stenting around the aortic arch requiring bypass
to at least one of the neck vessels) and fenestrated/
branched graft total endovascular approach to thor-
acoabdominal aneurysms (TAAAs), and highest for patients
who had a visceral hybrid repair (involving aortic
debranching of the visceral segment and retrograde bypass
from the distal aorta or iliac arteries) (Table 3). Overall
30-day mortality was 29/235 (12.3%). 4/23 (17.4%) SCI
patients died within 30 days v 25/212 (11.8%) patients who
did not develop SCI. 4 patients who died on table were not
included in these figures as their SCI status was unknown.
The patients who developed SCI had longer procedure
times than those without SCI (median times of 460 versus
240 min respectively) and required more extensive use
of endovascular stents (median 4 versus 2). No patients
developed SCI with less than 54% of aortic coverage (Fig. 2).
Table 4 shows the results of logistic regression model-
ling. The percentage of aorta stented was significantly
higher in patients who developed SCI even when correcting
for all other factors; adjusted odds ratio per 10% increase in
aortic coverage 1.78 [95% CI 1.18e2.71], p Z 0.007.
Another observation of note is that the visceral hybrid
procedure appeared to carry the highest crude risk of SCI
(odds ratio 13.7, p Z 0.001) but it did not appear to be an
independent risk factor for SCI when corrected for all other
variables; odds ratio 0.97, p Z 0.976. Patients presenting
with acute aortic syndrome appeared to be at considerably
increased risk of SCI even after adjustment for all other
factors; odds ratio (relative to thoracic aneurysm proce-
dures alone) 16.6[95% CI 1.3e205], p Z 0.029. However,
this result is difficult to interpret as the confidence interval
is very wide and the level of confounding between groups
is high.
SCI developed in 5 of the 89 cases where the LSA had
been covered compared with 17 of the 130 cases left
uncovered. Therefore, in this series, coverage of the LSA
appeared to reduce the risk of spinal cord ischaemia, even
after adjustment for the other factors, but this was not
statistically significant.Table 3 Risk of spinal cord ischaemia and permanent
paraplegia by type of procedure.
Procedure Spinal Cord
Ischaemia
Paraplegia
TEVAR 2/111 (1.8%) 1/111 (0.9%)
Fenestrated/Branched Graft 2/14 (14.3%) 1/14 (7.1%)
Arch Hybrid 3/30 (10%) 2/30 (6.7%)
Visceral Hybrid 16/80 (20%) 9/80 (11.3%)
Global SCI risk 23/235 (9.8%) 13/235 (5.5%)Discussion
These data demonstrate clearly that the greater the length
of the aorta covered, the greater the risk of developing
paraplegia. Other series have found that length of aorta
covered is an important factor for developing spinal cord
ischaemia with 20.5 cm being reported as a critical
length.18 In our series the shortest length of aorta covered
by stent that developed SCI was 27.4 cm. This equated with
percentage coverage of 55%. Martin et al. quoted an odds
ratio of 2 for every 10% aorta covered20 and this very similar
to the odds ratio of 1.78 presented for this series. It has
long been recognized that the anterior spinal artery
receives important contributions from branches of the
vertebrals, intercostals, lumbars and internal iliacs22 and
moreover this extrinsic blood supply varies amongst indi-
viduals. Increasing coverage of the collateral blood supply
to the spinal cord is the principle mechanism of SCI based
upon these observations and others, and underlines the
importance of careful pre-procedural planning to minimize
aortic coverage as well as avoidance of peri-operative
hypotension in this vulnerable group.
This study encompassed patients with both a heteroge-
nous group of conditions (atherosclerotic degenerative
aneurysms, chronic Type B dissections and acute aortic
syndromes) and different endovascular and hybrid solu-
tions. Underlying pathology did not appear to predict risk of
developing SCI although patients presenting with acute
aortic syndrome may fare particularly poorly when account
is taken for other confounders. One of the problems in
reporting outcomes and events for thoracic aortic endo-
vascular intervention is the disparity in the magnitude of
procedures performed. These range from single thoracic
stents to cover a penetrating atherosclerotic ulcer or
dissection tear entry point through to hybrid procedures
involving aortic visceral debranching, extra-anatomic
revascularisation and multiple stents deployed in the
thoracic and abdominal aorta. Manifestly risk of SCI
increases significantly depending on the magnitude of
procedure necessary, and we have attempted to categorise
Table 4 Results from logistic regression analysis of factors associated with spinal cord ischaemia (SCI) in 231 patients
undergoing thoracic or thoracoabdominal endovascular intervention.
Variablea SCI group
N Z 23
No SCI group
N Z 208
Crude odds ratio
[95% CI]
p-value
Adjusted bodds ratio
[95% CI]
p-value
Pre-operative data
Age (years) 69.7 (7.7) 66.7 (13.1) 1.24 [0.84e1.84] 0.84 [0.42e1.67]
Odds ratio per 10 year increase [0] [0] 0.276 0.614
Sex
Male 12 (52) 139 (67) Ref Ref
Female 11(48) 69 (33) 1.85 [0.77e4.40] 0.166 1.81 [0.49e6.74] 0.374
Indication
Aneurysm (TAA) 16 (70) 115 (55) Ref Ref
Chronic dissection 3 (13) 41 (20) 0.53 [0.15e1.90] 0.326 0.45 [0.08e2.57] 0.369
Acute aortic syndrome 4 (17) 52 (25) 0.55 [0.18e1.73] 0.310 16.58 [1.34e205.2] 0.029
Urgency
Elective 16 (70) 106 (51) Ref Ref
Emergency/urgent 6 (26) 66 (32) 0.60 [0.22e1.62] 0.314 0.41 [0.08e2.18] 0.284
Missing 1 (4) 36 (17) e e
Peri-operative data
Type of procedure
TEVAR 2 (9) 108 (52) Ref Ref
Fenestrated/branched 2 (9) 12 (6) 9.00 [1.16e69.82] 0.036 54.7 [0.86e3461] 0.059
Arch hybrid 3 (13) 25 (12) 6.48 [1.03e40.86] 0.047 2.17 [0.20e23.37] 0.522
Visceral hybrid 16 (69) 63 (30) 13.71 [3.05e61.61] 0.001 0.97 [0.11e8.63] 0.976
Procedure duration (mins)a 460 {345e550} 240 {135e505} 4.04 [1.80e9.05] 7.76 [1.19e50.71]
Increase per log(hour) [0] [23] 0.001 0.032
Percentage of aorta covered 76 (15) 54 (17) 1.92 [1.42e2.58] 1.78 [1.18e2.71]
Odds ratio per 10% increase [5] [40] <0.001 0.007
Spinal drain used
No 4 (17) 49 (23) Ref Ref
Yes 18 (78) 120 (58) 1.84 [0.59e5.71] 0.293 2.27 [0.28e18.08] 0.440
Missing 1 (4) 39 (19) e e
Subclavian artery covered
No 17 (74) 113 (55) Ref Ref
Yes 5 (22) 84 (40) 0.40 [0.14e1.12] 0.080 0.40 [0.10e1.62] 0.200
Missing 1 (4) 11 (5) e e
a All continuous variables presented as mean (SD) apart from procedure duration which was positively skewed and is presented as
median {interquartile range} and log transformed for inclusion in the logistic regression model. Numbers in square brackets indicate
number with missing covariates. All categorical variables presented as number (%).
b Adjusted for all other variables in the table. Note that adjusted model reduced to 17 SCI cases in 131 patients due to missing
covariates.
Risk of SCI in Thoracic Aortic Stenting 733procedures into appropriate groups so that accurate
reporting of risk can be undertaken.
Our SCI rate for TEVAR was low at 1.9%, and this figure
compares well with other single centre series and registry
data that quotes a range of between 0 and 10%. The SCI
rate became progressively higher for the arch hybrid group,
branch/fenestrated group and visceral hybrid group(See
Table 3). Our crude logistic regression results suggest that
the risk increases with the complexity and extent of
procedure performed, but after adjustment for
confounders it is possible that fenestrated and branched
procedures carry the greatest risk of SCI.
Table 1 shows data from published series for endovas-
cular treatment of the arch and thoracoabdominal
segments of the aorta. Across this series there is hetero-
geneity of procedure performed, with 7 papers reporting
a total endovascular approach, and 5 papers reportinga combined surgical and endovascular hybrid approach. Our
own initial experience of 29 hybrid procedures was very
encouraging with no episodes of SCI reported,23 but we now
report an SCI rate of 20%. Nine patients had complete
paraplegia, whilst four experienced varying degrees of
recovery giving a permanent paraplegia rate at 30 days of
11.3%. One would expect that a learning curve effect would
have meant the global SCI rate fell over time; in fact we
observed the opposite effect, with 4 episodes of SCI
complicating the first 60 cases, and 8 complicating cases
181e235. A possible explanation for this finding is that
progressively more complex cases have been taken on over
time presenting with more extensive aneurysmal disease.
12/80 visceral hybrid cases had stents extending into the
common iliac arteries, necessitating use of the external
iliac artery as the site for anastomosis of the retrograde
visceral bypass grafts. Four of these patients developed SCI
734 S.L. Drinkwater et al.and one of them subsequently died. We recorded the inci-
dence of internal iliac coverage on post-operative CT scans.
This was observed in 5 of the 187 CT scans examined and
one patient of those five went on to develop SCI (20%). 2/80
also involved a concomitant arch hybrid procedure. The
high in-hospital mortality associated with paraplegia was
reinforced in this study, with 4 patients dying during the in-
hospital episode. This observation has been made by other
centres, with Greenberg demonstrating that the two of
nine patients treated for TAAAs that developed SCI both
suffered late mortality as a direct result of the original
complication.24
Coverage of the left subclavian artery (LSA) without
revascularisation is known to carry a potential risk of arm
ischaemia, myocardial infarction (with a patent left
internal mammary graft), hindbrain stroke (with a domi-
nant left vertebral artery) and SCI. The EUROSTAR registry
involving 606 patients undergoing TEVAR showed that
coverage of the LSA was one of four factors associated with
increased risk of SCI on multivariate analysis (odds ratio
3.9).16 However this experience is not ubiquitous and
several studies have failed to demonstrate this.18,20 Our
study also failed to demonstrate a significant association,
an observation that we ascribe to the fact that in our series
most cases where the subclavian artery was covered
involved stents confined to the thoracic aorta alone.
Our usual practice is to employ the use of spinal CSF
drainage in all patients considered high risk, but use did not
appear to be associated with reduced risk of SCI. On the
contrary, there was some evidence to suggest it was asso-
ciated with an increased risk of SCI, even after adjustment
for confounding variables such as urgency, indication and
procedure type. The result is non-significant but the odds
ratio of approximately 2 remains unchanged between the
crude and adjusted models, so does not appear to be
strongly affected by confounding. CSF drainage has been
reported to reduce the incidence of SCI in open TAAA
repair25 and several groups have advocated its use in
endovascular repair. However spinal drainage is not without
complications including intra-spinal haematoma formation,
infection and subdural haematoma. A policy of selective
drainage for high risk patients (long coverage lengths,
previous aortic surgery, and left SCA coverage without
revascularisation) may offer the advantage of CSF drainage
for those requiring it without subjecting low risk patients to
possible complications.19 Our data also showed that one
third of patients showed improvement in function following
paraplegia. SCI can develop up to three weeks after
stenting, and immediate CSF drainage and blood pressure
augmentation can rescue the situation entirely or result in
a better functional outcome.
Limitations of the study
We acknowledge that there are limitations to this study.
The extent of missing data is problematic and limits the
generalisability of our results to other cohorts of patients.
Strategies for including patients with missing data in the
adjusted models would be complex and possibly misleading
as many of the important missing covariates appear to
relate to the SCI outcome making conventional imputation
methods inappropriate. Although four patients who haddeveloped SCI died before 30 days on ITU, we included
them in the multivariate analysis as we felt the factors that
may have played a role in the development of SCI were still
valid.
In summary, of the factors we have investigated here,
length of aortic coverage was the most significant risk
factor for the development of SCI in patients undergoing
endovascular repair of the thoracic and thoracoabdominal
aorta. This has important implications for selection of
patients for treatment and the risk-benefit ratios on an
individual basis. For those presenting with extensive
aneurysmal disease mandating significant aortic coverage
careful consideration about the threshold diameter for
intervention needs to be made and this should be factored
into the consent process for each individual patient. It is to
be hoped that further improvements in non-invasive
imaging of the spinal cord blood supply may further help
guide intervention on a personalised basis in the future.34
We would advocate routine use of adjuncts (maintenance
of mean arterial pressure of over 80mmHg and spinal drain)
in all patients undergoing stenting procedures where
coverage exceeds half their native aorta, and vigilance in
the post-operative period once the spinal drain has been
removed for any developing neurological defect.
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